株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

リキッドバイオプシーの世界市場

The World Liquid Biopsy Market

発行 Kalorama Information 商品コード 876845
出版日 ページ情報 英文 210 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.43円で換算しております。
Back to Top
リキッドバイオプシーの世界市場 The World Liquid Biopsy Market
出版日: 2019年05月30日 ページ情報: 英文 210 Pages
概要

当レポートでは、世界のリキッドバイオプシー市場を調査し、癌の診断、治療およびモニタリングに関する情報を提供しており、現在の検査と開発中の検査、競合要因、市場動向、癌の種類別による市場の分析、および主要企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 リキッドバイオプシー技術

  • イントロダクション
  • 現在の主要なリキッドバイオプシー技術

第3章 循環腫瘍DNA (ctDNA) リキッドバイオプシー

  • イントロダクション
  • リキッドバイオプシーにおけるctDNAのメリット・デメリット
  • 現在のctDNA型リキッドバイオプシー検査
  • 開発中のctDNA型リキッドバイオプシー検査

第4章 循環腫瘍細胞 (CTCs) リキッドバイオプシー

  • イントロダクション
  • CTC型リキッドバイオプシー検査の開発における課題
  • CTC型リキッドバイオプシー検査
  • 開発中のCTC型リキッドバイオプシー検査

第5章 細胞外小胞およびその他のリキッドバイオプシー

  • イントロダクション
  • 細胞外小胞/その他アナライトに基づいたリキッドバイオプシー検査

第6章 マルチアナライトリキッドバイオプシー検査

  • イントロダクション
  • マルチアナライトに基づくリキッドバイオプシー検査
  • 開発中のマルチアナライトに基づくリキッドバイオプシー検査

第7章 研究目的専用のリキッドバイオプシー検査

  • イントロダクション
  • 研究目的専用のリキッドバイオプシー検査

第8章 リキッドバイオプシー産業の分析

  • イントロダクション
  • 競合のティア
  • 競合要因
  • 重要な市場動向
  • リキッドバイオプシー市場から撤退した企業

第9章 リキッドバイオプシー市場

  • 市場概要
  • 市場予測

第10章 市場:アナライト別

  • 循環腫瘍DNA
  • 循環腫瘍細胞
  • 細胞外小胞およびその他のアナライト
  • マルチアナライト

第11章 市場:用途別

  • 治療ガイダンス・モニタリング
  • 診断/スクリーニング
  • 疾病の予後

第12章 市場:癌の種類別

  • 乳癌
  • 大腸癌
  • 肺癌
  • 卵巣癌
  • 前立腺癌
  • その他の癌
  • 全癌検査

第13章 リキッドバイオプシー企業のプロファイル

目次
Product Code: 19-038

Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer.

This report, “The World Liquid Biopsy Market”, from Kalorama Information, contains up-to-date information and useful data points for business planning:

  • Research vs. Clinical Liquid Biopsy
  • The Market for Liquid Biopsy by Region
  • The Market for Liquid Biopsy Market by Type of Analyte
  • The Market for CTC-based Liquid Biopsy
  • The Market for ctDNA-based Liquid Biopsy
  • The Market for EV and Exosome-based Liquid Biopsy
  • The Market for Multi-Analyte-based Liquid Biopsy
  • The Market for Other Liquid Biopsy
  • Liquid Biopsy Market by Type of Cancer (Breast, Lung, Colorectal, Ovarian, Prostate, Pan-Cancer, Other Cancer)
  • Selected ctDNA-based Liquid Biopsy Tests in Development
  • Selected Market-Available CTC-based Liquid Biopsy Tests, 2019
  • Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2019

While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they have risks and limitations and limitations, some of which can be overcome by the use of liquid biopsy in clinical oncology, as an alternative or complementary technique to the current standards of care.

Liquid biopsy testing has many potential applications in aspects of clinical oncology, including:

  • Early detection and diagnosis / screening
  • Alternative testing method when tissue biopsy is difficult/impossible, or when the primary site of metastatic disease is unknown
  • Therapy personalization and monitoring - by molecular characterization of a patient's disease, clinicians can select the optimal course of therapy and monitor efficacy over time, as well as quickly react to adjust therapy should treatment resistance arise
  • Disease monitoring - to observe disease progression, tumor evolution, residual disease, and early detection of recurrence
  • Prognosis of disease

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • INTRODUCTION
  • LIQUID BIOPSY TECHNOLOGIES
  • INDUSTRY STRUCTURE
  • LIQUID BIOPSY MARKET REVENUES AND FORECAST
    • Figure 1-1: Global Liquid Biopsy Market by Geographic Region, 2016 (%)
    • Table 1-1: Global Liquid Biopsy Market Forecast by Region ($ millions), 2018-2023
    • Figure 1-2: Global Liquid Biopsy Market Forecast by Region $ millions), 2018-2023

CHAPTER TWO: LIQUID BIOPSY TECHNOLOGIES

  • INTRODUCTION
    • Table 2-1: Comparison of Tissue and Liquid Biopsy
  • CURRENT MAJOR LIQUID BIOPSY TECHNOLOGIES
    • Table 2-2: Advantages and Limitations of Major Liquid Biopsy Technologies

CHAPTER THREE: CIRCULATING TUMOR DNA (CTDNA) LIQUID BIOPSY

  • INTRODUCTION
  • ADVANTAGES AND LIMITATIONS OF CTDNA IN LIQUID BIOPSY
  • CURRENT CTDNA-BASED LIQUID BIOPSY TESTS
    • Table 3-1: Selected Market-Available ctDNA-based Liquid Biopsy Tests, 2019
  • Biocartis
  • Biocept
  • Biodesix
  • CellMax Life
  • Circulogene
  • Diacarta
  • Epigenomics
  • Foundation Medicine
  • Guardant Health
  • Inivata
  • LungLife AI
  • Myriad Genetics
  • NeoGenomics
  • OncoDNA
  • Personal Genomic Diagnostics
  • QIAGEN
  • Resolution Biosciences
  • Roche Diagnostics
  • Sysmex-Inostics
  • CTDNA-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
    • Table 3-2: Selected ctDNA-based Liquid Biopsy Tests in Development
  • Exact Sciences
  • Freenome
  • GRAIL
  • Personal Genome Diagnostics
  • Tempus

CHAPTER FOUR: CIRCULATING TUMOR CELLS (CTCS) LIQUID BIOPSY

  • INTRODUCTION
  • CHALLENGES IN THE DEVELOPMENT OF CTC-BASED LIQUID BIOPSY TESTS
  • CTC-BASED LIQUID BIOPSY TESTS
    • Table 4-1: Selected Market-Available CTC-based Liquid Biopsy Tests, 2019
  • Adaptive Biotechnologies
  • Biocept
  • CellMax Life
  • Epic Sciences
  • GILUPI
  • LungLife AI
  • Menarini-Silicon Biosystems
  • QIAGEN
  • CTC-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
    • Table 4-2: Selected CTC-based Liquid Biopsy Tests in Development, 2019
  • ANGLE
  • Epic Sciences
  • Liquid Biotech USA

CHAPTER FIVE: EXTRACELLULAR VESICLES AND OTHER LIQUID BIOPSY

  • INTRODUCTION
  • LIQUID BIOPSY TESTS BASED ON EXTRACELLULAR VESICLES / OTHER ANALYTES
    • Table 5-1: Selected Market-Available Liquid Biopsy Tests based on Extracellular Vesicles / Other Analytes, 2019
  • Biodexis
  • Exosome Diagnostics
  • Hologic
  • MDxHealth
  • Vermillion
  • EXTRACELLULAR VESICLE/OTHER ANALYTE-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
    • Table 5-2: Selected Extracellular Vesicle/Other Analyte-based Liquid Biopsy Tests in Development, 2019
  • Circulogene
  • OncoCyte
  • QIAGEN
  • Resolution Biosciences
  • VolitionRx

CHAPTER SIX: MULTI-ANALYTE LIQUID BIOPSY TESTS

  • INTRODUCTION
  • LIQUID BIOPSY TESTS BASED ON MULTIPLE ANALYTES
    • Table 6-1: Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2019
  • Biocept
  • Biodesix
  • Foundation Medicine
  • LungLife AI
  • NeoGenomics
  • OncoDNA
  • MULTIPLE ANALYTE-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT
    • Table 6-2: Selected Multi Analyte-based Liquid Biopsy Tests in Development, 2019
  • Exact Sciences
  • Freenome
  • GRAIL
  • LungLife AI

CHAPTER SEVEN: LIQUID BIOPSY TESTS FOR RESEARCH USE ONLY

  • INTRODUCTION
  • LIQUID BIOPSY TESTS FOR RESEARCH USE ONLY
    • Table 7-1: Selected Liquid Biopsy Tests for Research Use Only, 2019
  • Agena Bioscience
  • ANGLE
  • DiaCarta
  • Exosome Diagnostics
  • Guardant Health
  • Natera
  • QIAGEN

CHAPTER EIGHT: LIQUID BIOPSY INDUSTRY ANALYSIS

  • INTRODUCTION
  • TIERS OF COMPETITION
    • Table 8-1: Selected Participants in the Liquid Biopsy Market, 2019
  • COMPETITIVE FACTORS
  • SIGNIFICANT MARKET TRENDS
    • Table 8-2: Significant Trends in the Liquid Biopsy Market, 2019
  • Personalized Medicine
  • Increasing Global Life Expectancy
  • New Liquid Biopsy Products
  • Increasing Accessibility of Genetic Testing
    • Figure 8-1: Laboratory Testing Sites - Tests Performed by Vendor vs. Testing Performed by Outside Labs (%)
  • Regulatory Hurdles
  • Third-Party Payor Coverage
  • Demonstrated Clinical Utility
  • Incidence Rates of Specific Cancers
  • COMPETITORS NO LONGER IN THE LIQUID BIOPSY MARKET
    • Table 8-3: Summary of Companies That Have Exited the Liquid Biopsy Market

CHAPTER NINE: LIQUID BIOPSY MARKET

  • MARKET OVERVIEW
    • Figure 9-1: Global Liquid Biopsy Diagnostics Market Estimate by Analyte, 2018 (%)
    • Figure 9-2: Global Liquid Biopsy Diagnostics Market Estimate by Region, 2018 (%)
    • Figure 9-3: Global Liquid Biopsy Market Estimate by Type of Use, (Research Use, Clinical Diagnostics Use) 2018 (%)
    • Figure 9-4: Global Liquid Biopsy Market by Test Performance Model (In-House Labs, Outside Clinical Labs, Both Options Available) (%)
  • MARKET FORECAST
    • Table 9-1: Global Liquid Biopsy Market Forecast by Region - North America, Europe, Asia Pacific, Rest of World, World ($ millions), 2018-2023
    • Figure 9-5: Global Liquid Biopsy Market Forecast by Region - North America, Europe, Asia Pacific, Rest of World ( $ millions), 2018-2023

CHAPTER TEN: MARKET BY ANALYTE

  • CIRCULATING TUMOR DNA
    • Market Overview
    • Revenue Forecast
      • Table 10-1: Global Liquid Biopsy Market for ctDNA ($ millions), 2018-2023
  • CIRCULATING TUMOR CELLS
    • Market Overview
    • Revenue Forecast
      • Table 10-2: Global Liquid Biopsy Market for CTCs ($ millions), 2018-2023
  • EXTRACELLULAR VESICLES AND OTHER ANALYTES
    • Market Overview
    • Revenue Forecast
      • Table 10-3: Global Liquid Biopsy Market for Extracellular Vesicles ($ millions), 2018-2023
  • MULTIPLE ANALYTES
    • Market Overview
    • Revenue Forecast
      • Table 10-4: Global Liquid Biopsy Market for Multiple Analytes ($ millions), 2018-2023

CHAPTER ELEVEN: MARKET BY APPLICATION

  • THERAPY GUIDANCE AND MONITORING
    • Market Overview
    • Revenue Forecast
      • Table 11-1: Liquid Therapy for Therapy Guidance ($ millions), 2018-2023
  • DIAGNOSIS/SCREENING
    • Market Overview
    • Revenue Forecast
      • Table 11-2: Global Liquid Biopsy Market for Diagnosis and Screening ($ millions), 2018-2023
  • DISEASE PROGNOSIS
    • Market Overview
    • Revenue Forecast
      • Table 11-3: Global Liquid Biopsy Market for Disease Prognosis ($ millions), 2018-2023

CHAPTER TWELVE: MARKET BY CANCER TYPE

  • BREAST CANCER
    • Market Overview
    • Revenue Forecast
      • Table 12-1: Global Liquid Biopsy Market for Breast Cancer ($ millions), 2018-2023
  • COLORECTAL CANCER
    • Market Overview
    • Revenue Forecast
      • Table 12-2: Global Liquid Biopsy Market for Colorectal Cancer ($ millions), 2018-2023
  • LUNG CANCER
    • Market Overview
    • Revenue Forecast
      • Table 12-3: Global Liquid Biopsy Market for Lung Cancer ($ millions), 2018-2023
  • OVARIAN CANCER
    • Market Overview
    • Revenue Forecast
      • Table 12-4: Global Liquid Biopsy Market for Ovarian Cancer ($ millions), 2018-2023
  • PROSTATE CANCER
    • Market Overview
    • Revenue Forecast
      • Table 12-5: Global Liquid Biopsy Market for Prostate Cancer ($ millions), 2018-2023
  • OTHER CANCERS
    • Market Overview
    • Revenue Forecast
      • Table 12-6: Global Liquid Biopsy Market for Other Cancers ($ millions), 2018-2023
  • PAN-CANCER TESTS
    • Market Overview
    • Revenue Forecast
      • Table 12-7: Global Liquid Biopsy Market for Pan-Cancer Testing ($ millions), 2018-2023

CHAPTER THIRTEEN: LIQUID BIOPSY COMPANY PROFILES

  • TOP TEN COMPANIES IN THE LIQUID BIOPSY MARKET
    • Table 13-1: Top Ten Companies in the Liquid Biopsy Market
  • ADAPTIVE BIOTECHNOLOGIES
  • AGENA BIOSCIENCE, INC.
  • ANGLE, PLC
  • BIOCARTIS GROUP NV
  • BIOCEPT, INC.
  • BIODESIX
  • CELLMAX LIFE
  • CIRCULOGENE
  • DIACARTA, INC.
  • EPIC SCIENCES
  • EPIGENOMICS AG
  • EXACT SCIENCES
  • EXOSOME DIAGNOSTICS, INC.
  • FOUNDATION MEDICINE, INC.
  • FREENOME, INC.
  • GENOMIC HEALTH, INC.
  • GILUPI GMBH
  • GRAIL
  • GUARDANT HEALTH, INC.
  • HOLOGIC
  • INIVATA
  • LIQUID BIOTECH USA
  • LUNGLIFE AI (FORMERLY CYNVENIO BIOSYSTEMS)
  • MDXHEALTH
  • MENARINI-SILICON BIOSYSTEMS, SPA
  • MYRIAD GENETICS, INC.
  • NATERA, INC.
  • NEOGENOMICS LABORATORIES, INC.
  • ONCOCYTE CORPORATION
  • ONCODNA S.A.
  • PERSONAL GENOME DIAGNOSTICS
  • QIAGEN N.V.
    • Cell-free DNA Technologies
    • CTC Technologies
    • Exosome and miRNA Technologies
  • RESOLUTION BIOSCIENCES
  • ROCHE DIAGNOSTICS
  • SYSMEX-INOSTICS, INC.
  • TEMPUS
  • VERMILLION, INC.
  • VOLITIONRX
Back to Top